FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to therapeutic fluids adapted for medical infusion to a patient. A system for the treatment of diabetes in a patient is proposed, made with the possibility of provision of correction of daily therapy, containing: a self-monitoring blood glucose (hereinafter – SMBG) device made with the possibility of manual measurement of a blood glucose level in the patient at unevenly distributed time intervals; a delivery device made with the possibility of insulin supply to the patient in accordance with a drug delivery parameter including at least one of the following: a basal velocity and bolus; a storage device made with the possibility of storage of at least one measurement of the blood glucose level and at least one of the following: the drug delivery parameter and a carbon-insulin ratio (hereinafter – CIR) of the patient; and a setting module containing a processor and machine-executed instructions and made with the possibility, when machine-executed instructions are performed by the processor, of: extraction from the storage device of the first data including at least two measurements of the blood glucose level, episodically measured by SMBG device for the first day; extraction from the storage device of the second data including at least one of the following: the drug delivery parameter executed by the delivery device for the first day; and CIR, and determination after the last measurement of the blood glucose level for the first day, based on the first data and the second data, of correction of daily therapy, including change in at least one of the following: the basal velocity and CIR, wherein correction of daily therapy is to be used for the next day by the delivery device; at the same time, measurements of the blood glucose level, used for determination of correction of daily therapy, are provided by SMBG device exclusively.
EFFECT: invention provides increased efficiency of diabetes treatment.
14 cl, 17 dwg, 3 tbl
